[Pregnancy and immunomodulatory therapy in multiple sclerosis patients]

Nervenarzt. 2006 Jun;77(6):663-4, 666-8, 670. doi: 10.1007/s00115-006-2053-7.
[Article in German]

Abstract

Pregnancy and family planning issues are prominent concerns in the medical care of multiple sclerosis patients, since the disease onset often coincides with a period of life that is decisive in this regard. Multiple sclerosis is a chronic disorder with an unpredictable course and is widely treated with long-term immunomodulatory agents, raising questions regarding the complications and effects of these therapies on pregnancy. This paper gives an overview of the relevant literature and provides a basis for individual counselling of this group of multiple sclerosis patients.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Pregnancy
  • Pregnancy Complications / chemically induced*
  • Pregnancy Complications / prevention & control*

Substances

  • Immunologic Factors